Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

Stock Information

NASDAQLPCN
$0.53
NASDAQLPCN
Open
$0.52
Change
$0.01 (2.81%)
Day's Range
$0.49 - $0.56
52-Week Range
$0.36 - $1.89
Volume
118.3K
Market Cap
$47.3M